Southern Research Receives $7.5 Million Award to Discover New Therapies for Cystic Fibrosis Patients with Rare Mutations

In addition, through the Alabama Drug Discovery Alliance (ADDA), Southern Research and UAB established a program to look for potential new treatments for several rare genetic diseases such as Hurler's syndrome, with mutations similar to those found in some CF patients.